PlainRecalls
FDA Drug Low Class III Terminated

Albuterol Sulfate Inhalation Solution, 0.021% (0.63 mg/3mL), packaged in 5 pouches of 5 x 3mL Sterile Unit-Dose Vials For Inhalation per carton, Rx only, Mfd. for: Watson Laboratories, Inc., Corona, CA 92880; Mfd. by: Cipla Ltd., Verna, Goa INDIA, NDC 0591-3467-53.

Reported: August 9, 2017 Initiated: July 25, 2017 #D-1039-2017

Product Description

Albuterol Sulfate Inhalation Solution, 0.021% (0.63 mg/3mL), packaged in 5 pouches of 5 x 3mL Sterile Unit-Dose Vials For Inhalation per carton, Rx only, Mfd. for: Watson Laboratories, Inc., Corona, CA 92880; Mfd. by: Cipla Ltd., Verna, Goa INDIA, NDC 0591-3467-53.

Reason for Recall

Failed Impurities/Degradation Specifications: high out of specification results for related compound D.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
401,750 cartons
Distribution
Nationwide in the USA and Puerto Rico
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Albuterol Sulfate Inhalation Solution, 0.021% (0.63 mg/3mL), packaged in 5 pouches of 5 x 3mL Sterile Unit-Dose Vials For Inhalation per carton, Rx only, Mfd. for: Watson Laboratories, Inc., Corona, CA 92880; Mfd. by: Cipla Ltd., Verna, Goa INDIA, NDC 0591-3467-53.. Recalled by Teva Pharmaceuticals USA. Units affected: 401,750 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: high out of specification results for related compound D.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 9, 2017. Severity: Low. Recall number: D-1039-2017.